Back to Search
Start Over
Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study
- Authors :
- Wolf, J.
Overbeck, T.
Han, J. -Y.
Hochmair, M.
De Marinis, F.
Ohashi, K.
Smit, E. F.
Power, D.
Garon, E. B.
Groen, H. J. M.
Tan, D. S. W.
Waldron-Lynch, M.
Le Mouhaer, S.
Nwana, N.
Giovannini, M.
Heist, R. S.
Wolf, J.
Overbeck, T.
Han, J. -Y.
Hochmair, M.
De Marinis, F.
Ohashi, K.
Smit, E. F.
Power, D.
Garon, E. B.
Groen, H. J. M.
Tan, D. S. W.
Waldron-Lynch, M.
Le Mouhaer, S.
Nwana, N.
Giovannini, M.
Heist, R. S.
- Publication Year :
- 2020
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1238104957
- Document Type :
- Electronic Resource